Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Cencora, Inc.

USUSD
← Į Akcijų Filtrą
US:CORLSE:0HF3

Cencora, Inc. (LSE:0HF3) — Other Pharmaceuticals. Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 2. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie Įmonę

Svetainė
cencora.com
Sektorius
Health Care · Other Pharmaceuticals
Būstinė
Chesterbrook, United States
Generalinis Direktorius
Steven H. Collis
Darbuotojai
44 000
Įkurta
2001
Apyvartoje Esančios Akcijos
190.83 mln. 2026-07-31 duomenimis
Laisvai Apyvartinės Akcijos
180.25 mln.
Rinkos Kapitalizacija
58.98 mlrd. USD
Insaideriai
4.3%
Instituciniai Investuotojai
99.63%
Šaka (SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
ISIN
US03073E1055
LEI
AI8GXW8LG5WK7E9UD086
Išmokų Santykis
17.8%
FCF
4.06 mlrd. USD
12%
Skola
11.7 mlrd. USD
2.2 m. FCF
Dividendų Stažas
25 m.
Pelnas, FCF ir dividendai – už 12 mėnesių iki 30.06.2026 (naujausia įmonės ataskaita).
Aprašymas

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Biržos ir Tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksCOR pagrindinisUSD323.85 +0.78%paprastosios akcijos
LSE London Stock Exchange0HF3 IOBUSD304.73 +0.00%paprastosios akcijos

Kaina per 3 Mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Per metus US:COR: 2.4 USD (4 išm.)

Cencora, Inc. (COR) moka dividendus kas ketvirtį. Per metus (12 mėnesių iki ir įskaitant naujausią paskelbtą mokėjimą): 2.4 USD už akciją (mokėjimai: 4). Tai sudaro apie 0.74% dabartinės akcijų kainos. Pagal išmokų istoriją kita ex-dividendų data tikėtina apie 13.11.2026. Nepertraukiamų dividendų metai: 25.

Ex DataIšmokaSuma%TipasTikeris
2026-08-142026-08-310.6000 USD0.2/0.7 %kas ketvirtįUS:COR
2026-05-152026-06-010.6000 USD0.2/0.7 %kas ketvirtįUS:COR
2026-02-132026-03-020.6000 USD0.2/0.7 %kas ketvirtįUS:COR
2025-11-142025-12-010.6000 USD0.2/0.7 %kas ketvirtįUS:COR
2025-08-152025-09-030.5500 USD0.2/0.7 %kas ketvirtįUS:COR
2025-05-162025-06-020.5500 USD0.2/0.7 %kas ketvirtįUS:COR
2025-02-142025-03-030.5500 USD0.2/≈0.7 %kas ketvirtįUS:COR
2024-11-152024-11-290.5500 USD0.2/≈0.7 %kas ketvirtįUS:COR
2024-08-092024-08-260.5100 USD0.2/≈0.6 %kas ketvirtįUS:COR
reklama

Didžiausi Akcininkai

TurėtojasDalisAkcijosAtaskaitos Data
BlackRock9.54%18.21 mln.2026-06-30
Vanguard Capital Managem…6.49%12.38 mln.2026-06-30
Vanguard Portfolio Manag…5.04%9.61 mln.2026-06-30
State Street Corporation4.86%9.27 mln.2026-06-30
T. Rowe Price Investment…3.88%7.41 mln.2026-06-30
Price (T.Rowe) Associate…3.74%7.13 mln.2026-06-30
JPMORGAN CHASE & CO3.11%5.94 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…3.07%5.87 mln.2026-06-30
Geode Capital Management…2.86%5.45 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.64%5.04 mln.2026-06-30
Boston Partners2.55%4.87 mln.2026-06-30
Wellington Management Gr…2.39%4.56 mln.2026-06-30
T. ROWE PRICE CAPITAL AP…2.33%4.44 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.1%4.01 mln.2026-06-30
VANGUARD SPECIALIZED FUN…1.59%3.03 mln.2026-07-31
iShares Trust-iShares Co…1.36%2.59 mln.2026-08-31
Fidelity Concord Street…1.32%2.52 mln.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.25%2.38 mln.2026-08-31
VANGUARD INDEX FUNDS-Van…0.92%1.76 mln.2026-06-30
-Price (T.Rowe) U.S. Val…0.85%1.62 mln.2026-06-30
COLLIS STEVEN HOWARD (Of…≈0.16%305 9132025-09-16
CLEARY JAMES F. JR. (Chi…≈0.08%160 3572026-03-11
MAUCH ROBERT P. (Chief E…≈0.03%65 3932026-02-20
DURCAN DERMOT MARK (Dire…≈0.02%31 7672026-06-18
BATTAGLIA SILVANA (Offic…≈0.01%23 6242026-06-30
CAMPBELL ELIZABETH S (Of…≈0.01%19 4552026-08-24
GREENBERG LON R (Directo…≈0.01%17 1282026-09-16
KRIKORIAN LAZARUS (Offic…≈0.01%16 1692026-09-01
NALLY DENNIS M (Director…≈0.01%13 1882026-07-31
The Vanguard Group———
Walgreens Boots Alliance…——2025-02-06